Cardiome Pharma Corp. (CRME) Forms $1.43 Double Bottom; LMP Capital & Income Fund (SCD) Sentiment Is 0.63

LMP Capital and Income Fund Inc. is a closed ended balanced mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. The company has market cap of $234.32 million. It is co-managed by Clearbridge Investments, LLC, Western Asset Management Company Limited, and Western Asset Management Company. It has a 7.54 P/E ratio. The fund invests in public equity and fixed income markets across the globe.

Cardiome Pharma Corp. (CRME) formed double bottom with $1.39 target or 3.00% below today’s $1.43 share price. Cardiome Pharma Corp. (CRME) has $50.66 million valuation. The stock increased 1.42% or $0.02 during the last trading session, reaching $1.43. About 27,163 shares traded. Cardiome Pharma Corp. (NASDAQ:CRME) has declined 11.02% since March 2, 2017 and is downtrending. It has underperformed by 27.72% the S&P500.

Cue Financial Group Inc. holds 0.38% of its portfolio in LMP Capital and Income Fund Inc. for 37,536 shares. Cornerstone Advisors Inc owns 156,931 shares or 0.26% of their US portfolio. Moreover, Rivernorth Capital Management Llc has 0.14% invested in the company for 122,016 shares. The Colorado-based Advisors Asset Management Inc. has invested 0.1% in the stock. Thomas J. Herzfeld Advisors Inc., a Florida-based fund reported 7,833 shares.

The stock decreased 1.66% or $0.22 during the last trading session, reaching $13.03. About 80,136 shares traded or 6.37% up from the average. LMP Capital and Income Fund Inc. (SCD) has risen 13.90% since March 2, 2017 and is uptrending. It has underperformed by 2.80% the S&P500.

Since January 1, 0001, it had 0 buys, and 1 sale for $101,899 activity.

Analysts await Cardiome Pharma Corp. (NASDAQ:CRME) to report earnings on March, 6. They expect $-0.19 earnings per share, down 5.56% or $0.01 from last year’s $-0.18 per share. After $-0.20 actual earnings per share reported by Cardiome Pharma Corp. for the previous quarter, Wall Street now forecasts -5.00% EPS growth.

Among 6 analysts covering Cardiome Pharma Corp (NASDAQ:CRME), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cardiome Pharma Corp has $12.50 highest and $3.50 lowest target. $8.10’s average target is 466.43% above currents $1.43 stock price. Cardiome Pharma Corp had 15 analyst reports since August 11, 2015 according to SRatingsIntel. The stock has “Buy” rating by Mackie on Friday, December 15. The stock of Cardiome Pharma Corp. (NASDAQ:CRME) has “Buy” rating given on Monday, August 21 by Canaccord Genuity. The firm has “Buy” rating by H.C. Wainwright given on Wednesday, November 22. As per Friday, August 14, the company rating was reinitiated by LB Securities. The firm earned “Buy” rating on Monday, July 17 by Canaccord Genuity. The stock of Cardiome Pharma Corp. (NASDAQ:CRME) earned “Hold” rating by Mackie on Wednesday, October 12. As per Wednesday, June 1, the company rating was initiated by H.C. Wainwright. The stock of Cardiome Pharma Corp. (NASDAQ:CRME) earned “Hold” rating by Zacks on Wednesday, August 26. The rating was initiated by Leerink Swann with “Outperform” on Thursday, December 22. The company was maintained on Wednesday, November 15 by Canaccord Genuity.

Investors sentiment increased to 1.09 in Q3 2017. Its up 0.26, from 0.83 in 2017Q2. It increased, as 2 investors sold Cardiome Pharma Corp. shares while 9 reduced holdings. 7 funds opened positions while 5 raised stakes. 13.54 million shares or 10.92% less from 15.20 million shares in 2017Q2 were reported. Moreover, Toronto Dominion National Bank & Trust has 0% invested in Cardiome Pharma Corp. (NASDAQ:CRME) for 84 shares. Financial Bank Of Montreal Can invested 0% of its portfolio in Cardiome Pharma Corp. (NASDAQ:CRME). Gru One Trading Lp has invested 0% in Cardiome Pharma Corp. (NASDAQ:CRME). Westfield Capital Mgmt L P has 4.86M shares. Scotia Cap reported 19,120 shares. Citadel Advsr Limited Liability Company holds 0% in Cardiome Pharma Corp. (NASDAQ:CRME) or 16,339 shares. Pnc Financial Group accumulated 0% or 51,400 shares. Bancshares Of Nova Scotia Tru accumulated 10 shares or 0% of the stock. Rock Springs Cap Management Limited Partnership holds 0.12% of its portfolio in Cardiome Pharma Corp. (NASDAQ:CRME) for 1.20 million shares. Alphaone Serv Limited Liability Co holds 600,625 shares. 16,718 are held by Art Ltd Liability Com. 3.09M were accumulated by Putnam Investments Limited Liability Company. Bancorp Of America De accumulated 45 shares. Jpmorgan Chase Com reported 158,697 shares or 0% of all its holdings. Ardsley Advisory Prns has 36,200 shares for 0.01% of their portfolio.